Mesa Laboratories Inc. (MLAB)
130.79
-0.31 (-0.24%)
At close: Jan 14, 2025, 3:59 PM
131.05
0.20%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 52.42 |
| Market Cap | 710.38M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -45.62 |
| PE Ratio (ttm) | -2.87 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 209.68 |
| Volume | 24,953 |
| Avg. Volume (20D) | 38,913 |
| Open | 132.64 |
| Previous Close | 131.10 |
| Day's Range | 129.21 - 132.82 |
| 52-Week Range | 83.68 - 147.34 |
| Beta | undefined |
About MLAB
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and ...
Industry Hardware, Equipment & Parts
Sector Technology
IPO Date Feb 29, 1984
Employees 736
Stock Exchange NASDAQ
Ticker Symbol MLAB
Website https://www.mesalabs.com
Analyst Forecast
According to 2 analyst ratings, the average rating for MLAB stock is "Buy." The 12-month stock price forecast is $140, which is an increase of 7.04% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 50.00%
Next Earnings Release
Mesa Laboratories Inc. is scheduled to release its earnings on Feb 3, 2025,
before market opens.
Analysts project revenue of $58.83M, reflecting a 10.02% YoY growth and earnings per share of 1.51, making a -25.25% decrease YoY.
Analysts project revenue of $58.83M, reflecting a 10.02% YoY growth and earnings per share of 1.51, making a -25.25% decrease YoY.
7 months ago ·
Source
+13.15%
Mesa Laboratories shares are trading higher after ...
Unlock content with
Pro Subscription
